Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Every N. R., Parsons L. S., Hlatky M., Martin J. S., Weaver W. D. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. N Engl J Med. 1996 Oct 24;335(17):1253–1260. doi: 10.1056/NEJM199610243351701. [DOI] [PubMed] [Google Scholar]
- Gibbons R. J., Holmes D. R., Reeder G. S., Bailey K. R., Hopfenspirger M. R., Gersh B. J. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med. 1993 Mar 11;328(10):685–691. doi: 10.1056/NEJM199303113281003. [DOI] [PubMed] [Google Scholar]
- Grines C. L., Browne K. F., Marco J., Rothbaum D., Stone G. W., O'Keefe J., Overlie P., Donohue B., Chelliah N., Timmis G. C. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993 Mar 11;328(10):673–679. doi: 10.1056/NEJM199303113281001. [DOI] [PubMed] [Google Scholar]
- Stone G. W., Grines C. L., Rothbaum D., Browne K. F., O'Keefe J., Overlie P. A., Donohue B. C., Chelliah N., Vlietstra R., Catlin T. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators. J Am Coll Cardiol. 1997 Apr;29(5):901–907. doi: 10.1016/s0735-1097(97)00041-7. [DOI] [PubMed] [Google Scholar]
- Yusuf S., Collins R., Peto R., Furberg C., Stampfer M. J., Goldhaber S. Z., Hennekens C. H. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J. 1985 Jul;6(7):556–585. doi: 10.1093/oxfordjournals.eurheartj.a061905. [DOI] [PubMed] [Google Scholar]
- Zijlstra F., de Boer M. J., Beukema W. P., Liem A. L., Reiffers S., Huysmans D., Hoorntje J. C., Suryapranata H., Simoons M. L. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J. 1996 Mar;17(3):382–387. doi: 10.1093/oxfordjournals.eurheartj.a014869. [DOI] [PubMed] [Google Scholar]
- Zijlstra F., de Boer M. J., Hoorntje J. C., Reiffers S., Reiber J. H., Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993 Mar 11;328(10):680–684. doi: 10.1056/NEJM199303113281002. [DOI] [PubMed] [Google Scholar]
- de Boer M. J., van Hout B. A., Liem A. L., Suryapranata H., Hoorntje J. C., Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol. 1995 Oct 15;76(11):830–833. doi: 10.1016/s0002-9149(99)80238-0. [DOI] [PubMed] [Google Scholar]